Welcome to CDC stacks | The National Amyotrophic Lateral Sclerosis (ALS) Registry first Biorepository pilot study expert panel meeting : March 26-27 summary report - 27707 | Stephen B. Thacker CDC Library collection

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

The National Amyotrophic Lateral Sclerosis (ALS) Registry first Biorepository pilot study expert panel meeting : March 26-27 summary report

Published Date:

2012

Language:

English

[PDF-1.01 MB]

Details:

Corporate Authors:

United States. Agency for Toxic Substances and Disease Registry.

Keywords:

[+]

Description:

This document has not been revised or edited to conform to agency standards. The findings and conclusions in this report are those of the meeting presenters and attendees and do not necessarily represent the views of the Agency for Toxic Substances and Disease Registry.

Minutes of the Meeting, March 26-27, 2012

Discuss on-going work in biorepositories and Amyotrophic Lateral Sclerosis (ALS) research and provide comments on a proposal for a biorepository of tissue samples to complement the National ALS Registry.

Document Type:

Report

Collection(s):

Stephen B. Thacker CDC Library collection

Place as Subject:

United States

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

National Amyotrophic Lateral Sclerosis (ALS) Biorepository Governance : February 12, 2013 summary report

Corporate Author:

United States. Agency for Toxic Substances and Disease Registry.

Published:

2013

Description:

Minutes of the Meeting, February 12, 2013 : Purpose: Discuss current governance practices with federal biorepositories and provide comments on proposed governance policies and procedures for the National ALS Biorepository.

File Type:

[PDF - 516.92 KB]
Integrating a Biorepository Into the National Amyotrophic Lateral Sclerosis Registry

Personal Author:

Horton, D. Kevin; Kaye, Wendy; Wagner, Laurie;

Published:

Nov 2016

Source:

J Environ Health. 79(4):38-40.

Description:

As part of our continuing effort to highlight innovative approaches to improving the health and environment of communities, the Journal is pleased to publish a bimonthly column from the Agency for Toxic Substances and Disease Registry (ATSDR). ATSDR ...

File Type:

[PDF - 129.14 KB]
ATSDR’s Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : July 22-23, 2015 summary meeting

Corporate Author:

United States. Agency for Toxic Substances and Disease Registry.

Published:

5/6/16

Description:

Due to the limited information on the unknown cause(s) of Amyotrophic Lateral Sclerosis (ALS), the Agency for Toxic Substances and Disease Registry (ATSDR) established the National ALS Registry in 2010. The primary purpose of the ALS Registry is to d...

File Type:

[PDF - 3.58 MB]
2016 Annual ALS Surveillance Meeting executive summary, August 3-4, 2016

Corporate Author:

United States. Agency for Toxic Substances and Disease Registry.

Published:

12/7/16

Description:

Due to the limited information on the unknown cause(s) of Amyotrophic Lateral Sclerosis (ALS), the Agency for Toxic Substances and Disease Registry (ATSDR) established the National ALS Registry in 2010. The primary purpose of the ALS Registry is to e...

File Type:

[PDF - 79.63 KB]
Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : August 1-2, 2017 summary report meeting transcript

Corporate Author:

United States. Agency for Toxic Substances and Disease Registry.

Published:

12/1/17

Description:

Amyotrophic Lateral Sclerosis (ALS) continues to be a mysterious fatal disease with no known cause(s) for approximately 90-95 percent of those diagnosed with the disease. It is for this reason that the Agency for Toxic Substances and Disease Registry...

File Type:

[PDF - 3.56 MB]